AW
PCVX icon

Avion Wealth’s Vaxcyte PCVX Stock Holding History

Avion Wealth’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Sell
15
-27
-64% -$1.47K ﹤0.01% 1655
2026
Q1 		$2K Buy
42
+27
+180% +$1.47K ﹤0.01% 900
2025
Q4 		$0 Hold
15
– – ﹤0.01% 1497
2025
Q3 		$0 Buy
+15
New +$497 ﹤0.01% 1457
2025
Q2 		– Sell
-21
Closed -$1K – 1496
2025
Q1 		$1K Hold
21
– – ﹤0.01% 904
2024
Q4 		$1K Hold
21
– – ﹤0.01% 901
2024
Q3 		$2K Buy
21
+6
+40% +$541 ﹤0.01% 706
2024
Q2 		$1K Buy
+15
New +$1.02K ﹤0.01% 790

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Avion Wealth's PCVX Position: Q2 2026 in Review

Avion Wealth reduced its Vaxcyte (PCVX) stake by 64% in Q2 2026, selling an estimated $1.47K and leaving 15 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

Avion Wealth first reported a position in PCVX in Q2 2024 and has held it in 8 quarters since. The position peaked at $2K in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Avion Wealth held 15 shares of Vaxcyte worth $0 as of Q2 2026.
  • Avion Wealth sold 27 Vaxcyte shares in Q2 2026, an estimated $1.47K.
  • Vaxcyte made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1655 holding.
  • Avion Wealth first reported a position in Vaxcyte in Q2 2024 and has held it in 8 quarters since.
  • Avion Wealth's Vaxcyte position peaked at $2K in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.